PitchBook-2025年一季度Agtech公共资产负债表和估值指南（英）-2025_8页_572kb

Agtech Public Comp Sheet and Valuation Guide Summary

Core Content Overview

This report provides an analysis of the performance, valuations, and revenue trends of various segments within the agricultural technology (Agtech) industry. It includes insights into stock returns, EBITDA margins, and revenue growth across precision agriculture, animal agriculture, animal biotech, indoor farming, and plant biotech. The data is sourced from PitchBook and Morningstar, and covers the period up to March 31, 2025.

Main Points and Key Insights

1. Agtech Performance Variations

• Public Markets Challenges: The S&P 500 declined by 5% and the Nasdaq by 10% in Q1 2025.
• Segment Variability:
  • Plant biotech incumbents saw a median stock price increase of 10%, indicating strong investor confidence.
  • Indoor farming solutions experienced a median stock price drop of 47%, highlighting ongoing operational and adoption challenges.
• Market Indexes:
  • S&P 500: -3% (1 week), -6% (30 days), -5% (90 days), -8% (YTD), 7% (1 year), 117% (5 years).
  • NASDAQ: -5% (1 week), -8% (30 days), -10% (90 days), -10% (YTD), 6% (1 year), 125% (5 years).
  • Russell 2000: -5% (1 week), -7% (30 days), -10% (90 days), -10% (YTD), -5% (1 year), 74% (5 years).
  • S&P Information Technology: -5% (1 week), -9% (30 days), -13% (90 days), -13% (YTD), 5% (1 year), 184% (5 years).

2. Revenue Growth Projections

• Recent Trajectory: Agtech companies experienced modest growth in 2023 (2%), but the sector contracted by 5% in 2024.
• 2025 Outlook: Revenue is projected to grow by 2% in 2025, driven by increased technology adoption.
• Challenges: Recovery is vulnerable to US import policies and international retaliatory tariffs.

3. EBITDA Margin Outlook

• Overall Stability: Median EBITDA margins are expected to remain stable, shifting slightly from 17% in 2024 to 16% in 2025.
• Animal Agriculture Superiority: This subsector is expected to see a significant margin expansion, from 23% in 2024 to 28% in 2025, due to improved operational efficiencies and higher-value product offerings.

Key Segments Analysis

1. Precision Agriculture

• Stock Returns:
  • AGCO: -2% (1 week), -5% (30 days), 16% (90 days), -4% (peak), 1% (YTD), -25% (1 year), 96% (3 years), 240% (5 years).
  • Caterpillar: -3% (1 week), -4% (30 days), 8% (90 days), -17% (peak), -8% (YTD), -10% (1 year), 184% (5 years).
  • Valmont Industries: -5% (1 week), -18% (30 days), -59% (90 days), -16% (peak), -6% (YTD), 25% (1 year), 169% (5 years).
• Revenue Trends:
  • Companies like AGCO and Deere show a positive trend in revenue growth.
  • Valmont Industries has seen a decline in recent years but remains stable at 1.9x EV/TTM revenue as of 3/31/2025.
• EV/Revenue Ratios:
  • Mean: 1.4x
  • Median: 1.5x

2. Animal Agriculture

• Stock Returns:
  • Mowi: -5% (1 week), 0% (30 days), 8% (90 days), 1% (peak), 7% (YTD), 0% (1 year), 24% (3 years), -18% (5 years).
  • SalMar: -5% (1 week), -3% (30 days), 1% (90 days), -10% (peak), -1% (YTD), -28% (1 year), 46% (3 years), -100% (5 years).
• Revenue Trends:
  • BayWa has shown consistent revenue growth.
  • SalMar and Mowi have seen mixed performance with some years of growth and others of decline.
• EV/Revenue Ratios:
  • Mean: 1.7x
  • Median: 1.5x

3. Animal Biotech

• Stock Returns:
  • Elanco Animal Health: -2% (1 week), -6% (30 days), -13% (90 days), -16% (peak), -13% (YTD), -36% (1 year), -53% (3 years), -6% (5 years).
  • Zoetis: -2% (1 week), -9% (30 days), -2% (90 days), -10% (peak), -1% (YTD), -3% (1 year), 40% (3 years), 119% (5 years).
• Revenue Trends:
  • Zoetis has shown consistent revenue growth.
  • Phibro Animal Health and Benchmark Holdings have seen mixed revenue performance.
• EV/Revenue Ratios:
  • Mean: 2.6x
  • Median: 2.7x

4. Indoor Farming

• Stock Returns:
  • AgriFORCE: -21% (1 week), -29% (30 days), -54% (90 days), -62% (peak), -55% (YTD), -94% (1 year), N/A (3 years), N/A (5 years).
  • Agrify: -4% (1 week), -6% (30 days), -39% (90 days), -35% (peak), -46% (YTD), 217% (1 year), N/A (3 years), N/A (5 years).
• Revenue Trends:
  • Local Bounti has shown positive growth in some periods but is generally volatile.
  • Village Farms has seen a consistent decline in revenue.
• EV/Revenue Ratios:
  • Mean: 1.8x
  • Median: 1.6x

5. Plant Biotech—Fast Growth

• Stock Returns:
  • Argo Living Soils: -3% (1 week), -20% (30 days), 209% (90 days), 186% (peak), 186% (YTD), 11% (1 year), N/A (3 years), N/A (5 years).
  • Bioceres Crop Solutions: 12% (1 week), 14% (30 days), -25% (90 days), -30% (peak), -32% (YTD), -64% (1 year), N/A (3 years), -7% (5 years).
• Revenue Trends:
  • Argo Living Soils and SLC Agricola have shown significant revenue growth.
  • Bioceres Crop Solutions and MustGrow Biologics have had fluctuating performance.
• EV/Revenue Ratios:
  • Mean: 1.9x
  • Median: 2.6x

6. Plant Biotech—Medium Growth and Incumbents

• Stock Returns:
  • BASF: -9% (1 week), -3% (30 days), 12% (90 days), 7% (peak), 13% (YTD), -13% (1 year), N/A (3 years), 4% (5 years).
  • Bayer: -9% (1 week), 1% (30 days), 19% (90 days), 13% (peak), 19% (YTD), -22% (1 year), N/A (3 years), -59% (5 years).
• Revenue Trends:
  • Coromandel International and Nufarm have shown consistent growth.
  • Dow and DuPont have had mixed revenue performance.
• EV/Revenue Ratios:
  • Mean: 3.0x
  • Median: 2.6x

Summary of Key Findings

• Performance Variability: Agtech segments exhibit wide variations in stock performance, with plant biotech incumbents performing well and indoor farming companies struggling.
• Revenue Growth: The sector experienced a contraction in 2024 but is expected to recover with a 2% growth in 2025.
• EBITDA Margins: Margins are expected to remain stable overall, with animal agriculture showing notable improvement.
• Valuation Trends:
  • Precision agriculture companies show a mean EV/TTM revenue ratio of 1.4x and median of 1.5x.
  • Animal agriculture companies have a mean EV/TTM revenue ratio of 1.7x and median of 1.5x.
  • Animal biotech companies show a mean EV/TTM revenue ratio of 2.6x and median of 2.7x.
  • Indoor farming companies have a mean EV/TTM revenue ratio of 1.8x and median of 1.6x.
  • Plant biotech—fast growth companies have a mean EV/TTM revenue ratio of 1.9x and median of 2.6x.
  • Plant biotech—medium growth and incumbents have a mean EV/TTM revenue ratio of 3.0x and median of 2.6x.

Conclusion

The Agtech sector has shown a mixed performance in 2025, with some segments like plant biotech and animal agriculture performing better than others such as indoor farming. While the overall revenue growth is expected to recover, it remains vulnerable to external factors like import policies and tariffs. EBITDA margins are projected to remain stable, with animal agriculture leading the way in profitability. Investors should closely monitor these trends and consider the risks associated with each segment.